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Background: Coronary artery disease (CAD) is the leading cause of death for individuals with type 2 diabetes mellitus (DM). Endothelial 
dysfunction which can be assessed by measuring the brachial artery flow-mediated dilatation (FMD) is known to be an important factor of 
atherosclerosis in type 2 DM, however it is controversial whether FMD correlates with coronary artery plaque burden. The purpose of this study is to 
clarify the association between FMD and coronary artery plaque burden using 320-slice multi-detector computed tomography in type 2 DM patients.
Methods: We enrolled 200 asymptomatic type 2 DM patients without history of CAD. All patients underwent cardiac computed tomography 
angiography (CCTA) using 320-slice multi-detector computed tomography and FMD. Laboratory tests, brachial-ankle pulse wave velocity, and carotid 
intima-media thickness (cIMT) were also assessed. We categorized patients based on the result of CCTA into 3 groups (Group 0: Absence of plaque, 
Group 1: Plaque with 0-49% stenosis, Group 2: Plaque with 50-99% stenosis and total occlusion), and compared FMD and other factors between 3 
groups.
Results: The mean age of the study participants was 64.0±9.7 years; 69.5% were men. Diabetic duration was 10.4±8.0 years and mean HbA1c 
level was 6.7±1.2%. Among 200 patients, 61 (30.5%), 81 (40.5%) and 58 (29%) were categorized into Group 0, 1 and 2 respectively. The difference 
in the FMD was clearly expressed between 3 groups (mean FMD±SD: 5.1±2.5% in Group 0, 4.5±2.4% in Group 1, 3.9±1.9% in Group 2 [p < 0.05]). 
Multivariate logistic regression analysis revealed FMD (OR 3.66, 95% CI 1.06-12.7, p < 0.05) as well as cIMT (OR 2.58, 95% CI 1.04-6.36, p < 0.05) 
and calcium score (OR 14.3, 95% CI 4.93-40.9, p < 0.05) as the independent predictors of significant coronary artery plaque burden.
Conclusions: This study shows that FMD was impaired regardless of CAD and reflected the severity of coronary artery plaque burden in type 2 DM 
patients.
